ATE141584T1 - Verfahren zum herstellen von simvastatin - Google Patents

Verfahren zum herstellen von simvastatin

Info

Publication number
ATE141584T1
ATE141584T1 AT92303920T AT92303920T ATE141584T1 AT E141584 T1 ATE141584 T1 AT E141584T1 AT 92303920 T AT92303920 T AT 92303920T AT 92303920 T AT92303920 T AT 92303920T AT E141584 T1 ATE141584 T1 AT E141584T1
Authority
AT
Austria
Prior art keywords
simvastatin
producing simvastatin
producing
lactone
formation
Prior art date
Application number
AT92303920T
Other languages
English (en)
Inventor
Rebecca L Dabora
Gregory L Tewalt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24787670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE141584(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE141584T1 publication Critical patent/ATE141584T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT92303920T 1991-05-01 1992-04-30 Verfahren zum herstellen von simvastatin ATE141584T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/694,164 US5159104A (en) 1991-05-01 1991-05-01 Process to simvastatin ester

Publications (1)

Publication Number Publication Date
ATE141584T1 true ATE141584T1 (de) 1996-09-15

Family

ID=24787670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92303920T ATE141584T1 (de) 1991-05-01 1992-04-30 Verfahren zum herstellen von simvastatin

Country Status (10)

Country Link
US (1) US5159104A (de)
EP (1) EP0511867B1 (de)
JP (1) JPH0764837B2 (de)
AT (1) ATE141584T1 (de)
CA (1) CA2067722A1 (de)
DE (1) DE69212884T2 (de)
DK (1) DK0511867T3 (de)
ES (1) ES2090507T3 (de)
GR (1) GR3021527T3 (de)
IE (1) IE73439B1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504436A (ja) * 1993-11-02 1997-05-06 メルク エンド カンパニー インコーポレーテッド トリオールポリケチドシンターゼをコードするｄｎａ
WO1997006128A1 (en) * 1995-08-03 1997-02-20 Gist-Brocades B.V. Selective process for the deacylation of acylated compounds
US5763653A (en) * 1997-03-13 1998-06-09 Ranbaxy Laboratories, Ltd. Key intermediates in the manufacture of simvastatin
CA2185961A1 (en) 1996-09-19 1998-03-20 K.S. Keshava Murthy Process for producing simvastatin
US5763646A (en) * 1997-03-13 1998-06-09 Ranbaxy Laboratories, Ltd. Process for manufacturing simvastatin from lovastatin or mevinolinic acid
ZA9810764B (en) * 1998-04-22 1999-08-13 Ranbaxy Lab Ltd An improved process of lactonization in the preparation of statins.
CA2240983A1 (en) 1998-06-18 1999-12-18 Yong Tao Process to manufacture simvastatin and intermediates
US6002021A (en) * 1998-06-29 1999-12-14 Industrial Technology Research Institute Process for preparing 6(R)-{2-8'(S)-2",2"-dimethylbutyryloxy-2'(S)-6'(R)-dimethyl-1',2',6'7',8' 8'A(R)-hexahydronapthyl-1'(S)-ethyl}-4(R)-hydroxy-3,4,5,6-tetrahydro-2H- pyran-2-one
SI20116A (sl) 1998-12-02 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za pripravo simvastatina in njegovih analogov
US6391583B1 (en) * 1998-12-18 2002-05-21 Wisconsin Alumni Research Foundation Method of producing antihypercholesterolemic agents
CA2388182A1 (en) 1999-10-27 2001-05-03 Merck & Co., Inc. Lactonization process
CA2389616A1 (en) * 1999-11-03 2001-05-10 Howard J. Smith & Associates Pty Ltd. Liver selective therapy
US6576775B1 (en) 2000-03-30 2003-06-10 Cheil Jedang Corporation Process for producing simvastatin
CZ2003554A3 (cs) * 2000-07-27 2003-08-13 Plus Chemicals, B. V. Vysoce přečištěný simvastatin
US6777552B2 (en) * 2001-08-16 2004-08-17 Teva Pharmaceutical Industries, Ltd. Processes for preparing calcium salt forms of statins
NL1017548C2 (nl) 2001-03-09 2002-09-10 Synthon Bv Een lactonisatie proces.
KR100407758B1 (ko) * 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
KR100435142B1 (ko) * 2002-01-09 2004-06-09 한미약품 주식회사 개선된 심바스타틴의 제조방법
CA2515179A1 (en) 2003-02-11 2004-08-26 Ferenc Korodi Process for preparing simvastatin having controlled ranges of simvastatin dimer content
CA2521095A1 (en) * 2003-04-01 2004-10-21 Plus Chemicals, B.V. Amorphous simvastatin calcium and methods for the preparation thereof
WO2005040107A2 (en) * 2003-10-21 2005-05-06 Diversa Corporation Methods for making simvastatin and intermediates
AU2004323102A1 (en) * 2004-09-08 2006-03-16 Jubilant Organosys Limited An improved process for lactonization in the preparation of statins
CN1754870A (zh) * 2004-09-30 2006-04-05 淮北市辉克药业有限公司 辛伐他汀的制备方法
GB0427491D0 (en) * 2004-12-16 2005-01-19 Avecia Ltd Process and compounds
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
US20110059493A1 (en) * 2007-08-27 2011-03-10 Brian Morgan Methods for Making Simvastatin and Intermediates
CN102690254B (zh) * 2008-05-09 2014-06-04 上海医药工业研究院 辛伐他汀铵盐中间体及其制备方法
CN101575286B (zh) * 2008-05-09 2013-06-19 上海医药工业研究院 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法
ES2343049B1 (es) 2008-10-15 2011-06-10 Neuron Biopharma, S.A. Biosintesis de derivados de monacolina j.
US8470805B2 (en) 2009-04-30 2013-06-25 Kaohsiung Medical University Processes for preparing piperazinium salts of KMUP and use thereof
TWI462739B (zh) 2010-11-02 2014-12-01 Univ Kaohsiung Medical Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
WO2014168933A1 (en) 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
US4584389A (en) * 1983-10-11 1986-04-22 Merck & Co., Inc. Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
JPH0749393B2 (ja) * 1987-06-03 1995-05-31 旭電化工業株式会社 新規化合物及びこれを用いた高脂血症治療薬
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US4866090A (en) * 1988-01-07 1989-09-12 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors

Also Published As

Publication number Publication date
CA2067722A1 (en) 1992-11-02
GR3021527T3 (en) 1997-01-31
IE73439B1 (en) 1997-06-04
IE921399A1 (en) 1992-11-04
ES2090507T3 (es) 1996-10-16
DK0511867T3 (da) 1996-09-09
EP0511867B1 (de) 1996-08-21
JPH05230052A (ja) 1993-09-07
EP0511867A1 (de) 1992-11-04
DE69212884T2 (de) 1997-02-27
JPH0764837B2 (ja) 1995-07-12
US5159104A (en) 1992-10-27
DE69212884D1 (de) 1996-09-26

Similar Documents

Publication Publication Date Title
DE69212884D1 (de) Verfahren zum Herstellen von Simvastatin
NO303574B1 (no) Ny fremgangsmÕte for fremstilling av 9-amino-6-demetyl-6-deoksytetracykliner
DE68913215D1 (de) Verfahren zur Herstellung hydraulischer Dämpfungsspalten.
ATE121066T1 (de) Verfahren zur herstellung von 6,12-dihydro-6- hydroxy-cannabidiol und dessen anwendung zur herstellung von trans-delta-9- tetrahydrocannabinol.
DE69430216D1 (de) Verfahren zum Herstellen von Doppelplüschgeweben
DE69431799D1 (de) Verfahren zur erzeugung von russen
AT372975B (de) Verfahren zum herstellen von monacolin k
DE59404214D1 (de) Verfahren zum herstellen von diglycerin
DE3855208D1 (de) Verfahren zur Herstellung von hochschlagfesten Polycarbonaten
DE69530592D1 (de) Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
ATE163096T1 (de) Verfahren zur herstellung von mikrostrukturkörpern
DE69201380D1 (de) Verfahren zum Herstellen von Rohrglas.
DE69013514D1 (de) Verfahren zum herstellen von bauelementen einer flüssigkeitskammer.
ATE218131T1 (de) Verfahren zur herstellung von mono-n- substituierten tetraazamakrocyclen
DE69208290D1 (de) Verfahren zum Herstellen von Formkörpern mittels CVD und daraus hergestellte Formkörper
DE69411254D1 (de) Verfahren zum kontinuierlichen Herstellen von Dimethylcarbonat
ATE175957T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-verbindungen
NO943370L (no) Fremgangsmåte for fremstilling av okso-produkter
DE59008624D1 (de) Verfahren zum Herstellen von kaschierten Formteilen.
ATE130597T1 (de) Verfahren zur herstellung von r-aminocarnitin und s-aminocarnitin.
ATE150003T1 (de) Verfahren zur herstellung von l-(-)-carnitin aus abfallprodukten mit entgegengesetzter konfiguration
DE69225560D1 (de) Verfahren zur Herstellung von Lactonen
ATE132535T1 (de) Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg
DE3582368D1 (de) Verfahren zur herstellung von epoxyden mittels mikroorganismen.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee